Description

HAEMORED-FCM 500

• FDA-approved IV treatment for iron deficiency. intolerant to oral therapy.
• Stable formulation, allowing a higher dose up to 1000mg.
• Improves Hb levels more rapidly compared to ferrous sulfate.
• Sustainably improves function, symptoms, and QOL, reduces the risk of hospitalization for worsening heart failure
• Effective in treating iron deficiency anemia in many chronic conditions.
• Rapid and significant replenishment of iron stores in pregnant women over a 12-week period with better compliance, improvement in fatigue scores as compared to Iron sucrose complex.
• The ease of dosing and efficacy contributes to compliance and an increase in Hb levels.
• Rapidly cleared from the circulation and is distributed primarily to the bone marrow (approximately 80%) liver and spleen.
• Effective safe and well tolerated in the treatment of iron deficiency in ND-CKD and PD-CKD patients.